Harrison C - Search Results

1

Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study.

Alimam S, Bewley S, Chappell LC, Knight M, Seed P, Gray G, Harrison C, Robinson S. Alimam S, et al. Among authors: harrison c. Br J Haematol. 2016 Oct;175(1):31-6. doi: 10.1111/bjh.14289. Epub 2016 Sep 9. Br J Haematol. 2016. PMID: 27612319 Free article.

2

Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.

Harrison C. Harrison C. Br J Haematol. 2005 May;129(3):293-306. doi: 10.1111/j.1365-2141.2005.05400.x. Br J Haematol. 2005. PMID: 15842653 Free article. Review.

3

Review: challenges in the management of thrombocytosis in young patients.

Robinson S, Harrison C. Robinson S, et al. Among authors: harrison c. Clin Adv Hematol Oncol. 2008 Feb;6(2):137-8, 141. Clin Adv Hematol Oncol. 2008. PMID: 18347565 Review. No abstract available.

4

Janus kinase inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?

Harrison C, Verstovsek S, McMullin MF, Mesa R. Harrison C, et al. Br J Haematol. 2012 May;157(4):426-37. doi: 10.1111/j.1365-2141.2012.09108.x. Epub 2012 Mar 29. Br J Haematol. 2012. PMID: 22463737 Free PMC article. Review.

5

Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: a physician survey.

Ellis MH, Lavi N, Vannucchi A, Harrison C. Ellis MH, et al. Among authors: harrison c. Thromb Res. 2014 Aug;134(2):251-4. doi: 10.1016/j.thromres.2014.04.032. Epub 2014 May 9. Thromb Res. 2014. PMID: 24842684

6

Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial.

Mead AJ, Milojkovic D, Knapper S, Garg M, Chacko J, Farquharson M, Yin J, Ali S, Clark RE, Andrews C, Dawson MK, Harrison C. Mead AJ, et al. Among authors: harrison c. Br J Haematol. 2015 Jul;170(1):29-39. doi: 10.1111/bjh.13379. Epub 2015 Mar 30. Br J Haematol. 2015. PMID: 25824940 Free article. Clinical Trial.

7

The use of JAK inhibitors for low-risk myelofibrosis.

Alimam S, McLornan D, Harrison C. Alimam S, et al. Among authors: harrison c. Expert Rev Hematol. 2015 Oct;8(5):551-3. doi: 10.1586/17474086.2015.1074858. Epub 2015 Aug 6. Expert Rev Hematol. 2015. PMID: 26343888

8

Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.

Beauverd Y, Radia D, Cargo C, Knapper S, Drummond M, Pillai A, Harrison C, Robinson S. Beauverd Y, et al. Among authors: harrison c. Haematologica. 2016 May;101(5):e182-4. doi: 10.3324/haematol.2015.139691. Epub 2016 Jan 27. Haematologica. 2016. PMID: 26819057 Free PMC article. No abstract available.

9

Experience with ruxolitinib in the treatment of polycythaemia vera.

Alimam S, Harrison C. Alimam S, et al. Among authors: harrison c. Ther Adv Hematol. 2017 Apr;8(4):139-151. doi: 10.1177/2040620717693972. Epub 2017 Apr 1. Ther Adv Hematol. 2017. PMID: 28491265 Free PMC article. Review.

10

Bone marrow niche dysregulation in myeloproliferative neoplasms.

Curto-Garcia N, Harrison C, McLornan DP. Curto-Garcia N, et al. Among authors: harrison c. Haematologica. 2020 May;105(5):1189-1200. doi: 10.3324/haematol.2019.243121. Epub 2020 Apr 2. Haematologica. 2020. PMID: 32241851 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,713 results

Search Page

Filters